Why did CLBT outperform forecasts in 2024?

Cellebrite DI Ltd. (CLBT) outperformed forecasts in 2024 due to several key factors:

1. **Strong Revenue Growth**: Cellebrite experienced significant revenue growth, with a 25% year-over-year increase in the second quarter and a 27% growth in subscription revenue. This was primarily driven by the company's successful launch of Cellebrite Federal Solutions and the integration of AI technology.
2. **Annual Recurring Revenue (ARR) Growth**: The company reported a 26% year-over-year increase in ARR, reaching $346 million by the end of June 2024. The ARR guidance raise indicated strong performance and future expectations.
3. **Adjusted EBITDA and Profitability**: Cellebrite increased its full-year 2024 outlook for revenue and adjusted EBITDA, reflecting strong performance and future expectations. The company achieved an adjusted EBITDA of $21.6 million and a 22.6% adjusted EBITDA margin.
4. **Market Position and Innovation**: The company's focus on AI integration and the Case to Closure platform resonated with customers, leading to increased traction and a growing customer base. The adoption of AI-powered solutions is expected to improve investigative speed, efficiency, and effectiveness.
5. **Strategic Initiatives**: Cellebrite's strategic initiatives, such as the expansion of its sales force and the establishment of Cellebrite Federal Solutions, have positioned the company for future growth. The company's strong market position and continuous innovation in digital intelligence solutions have been well received in the market.

In conclusion, Cellebrite DI Ltd.'s outperformance in 2024 can be attributed to its strong revenue growth, ARR increase, profitability, strategic market positioning, and continuous innovation in AI technology and product offerings.

|code|Ticker|Name|Date|Moving Average|market_code|
|---|---|---|---|---|---|
|CLBT|CLBT.O|Cellebrite DI|20250408|18.4000|185|

|code|Ticker|Name|Date|Net Fund Flow|Net Fund Flow (Block Order)|market_code|
|---|---|---|---|---|---|---|
|CLBT|CLBT.O|Cellebrite DI|20250106|-343920.345|-398569.8926|185|
|CLBT|CLBT.O|Cellebrite DI|20250107|134814.9612|90100.5109|185|
|CLBT|CLBT.O|Cellebrite DI|20250108|889323.4067|711724.6626|185|
|CLBT|CLBT.O|Cellebrite DI|20250110|-1964901.757|-1956226.7631|185|
|CLBT|CLBT.O|Cellebrite DI|20250113|-780030.6794|-763230.4015|185|
|CLBT|CLBT.O|Cellebrite DI|20250114|3087090.5414|2697554.0938|185|
|CLBT|CLBT.O|Cellebrite DI|20250115|3947320.2419|3764584.2406|185|
|CLBT|CLBT.O|Cellebrite DI|20250116|-1903827.3817|-1930084.5295|185|
|CLBT|CLBT.O|Cellebrite DI|20250117|-3901347.4302|-3609881.9947|185|
|CLBT|CLBT.O|Cellebrite DI|20250121|576760.7864|708515.6032|185|

|code|Ticker|Name|Date|Boll|RSI|KDJ|MACD|market_code|
|---|---|---|---|---|---|---|---|---|
|CLBT|CLBT.O|Cellebrite DI|20250408|18.8900|30.1737|22.2211|-0.1805|185|